CannonSiteCareCard(revised) 6/24/04 9:35 AM Page 1
Arrow® Cannon Catheter™ Site Care
The Arrow® Cannon Catheter™ II and Cannon™ II Plus catheters are constructed of different radiopaque polyurethane materials and therefore require separate site care details. Warning: Prior to catheter and skin prep, refer to appropriate Site Care sections to identify indwelling catheter body type. Site Care for Cannon™ II Plus Catheter** Site Care for Cannon Catheter™ II 1. Alcohol, alcohol-based solutions (e.g. Hibiclens®, ChloraPrep®), 1. IODINE-based solutions (e.g. Povidine-iodine), commercially
iodine-based solutions (e.g. Povidine-Iodine), mineral oil-based
available ExSept® are recommended as antiseptic solutions that
ointments, hydrogen peroxide or commercially available ExSept®
are accepted for use with this catheter.
is accepted for use with this catheter. 2. Mineral oil-based ointments are acceptable. 2. Ensure that solution is completely dry before applying an 3. Avoid use of alcohol, alcohol-based solutions (e.g. Hibiclens®,
ChloraPrep®) acetone, or hydrogen peroxide to clean catheter or
3. Avoid excessive or prolonged use of alcohol-based solutions
site care as this causes catheter degradation and failure may occur.
and ointments to clean catheter or site care. 4. Do not use any type of solvent to clean catheter or extension 4. Do not use acetone with this catheter, catheter degradation may occur.
lines. Catheter degradation and failure will occur. 5. Avoid use of ointments containing Polyethylene Glycol (PEG) 5. Avoid use of ointments containing Polyethylene Glycol (PEG)
on this catheter, with the exception of Bactroban®. 6. Clean skin around catheter using accepted solution antiseptics. 6. Clean skin around catheter using iodine-based antiseptics. Cover
Cover exit site care with sterile occlusive dressing for the entire
exit site with sterile occlusive dressing for the entire duration of
duration of implantation. If catheter swelling is observed,
implantation. If catheter swelling is observed, discontinue use
discontinue use and replace catheter.
• Wound dressings must be kept clean and dry. Caution: Patients must not swim, shower, or soak dressing while bathing. • If excessive perspiration or accidental wetting compromises adhesion of dressing, medical or nursing staff must change dressing
Heparinization: To maintain patency of catheter between treatments, a heparin-lock must be created in each lumen of catheter. Concentration of heparin used should be determined by hospital protocol. If catheter is not going to be used, it is recommended that catheter be flushed and re-packed with heparin every 48-72 hours. MR Environment: This device presents no additional risks to the patient or other individuals during use with shielded magnetic resonance (MR) systems up to 3.0-Tesla, but may produce some MR imaging artifact in the area of the device. More detailed information regarding the use of this device in an MR environment is available upon request.
CannonSiteCareCard(revised) 6/24/04 9:35 AM Page 2
Arrow® Cannon Catheter™ Site Care Compatibility Of Site Care Antiseptics1 Antiseptic Agents Cannon™ II Plus+, ¥ Cannon Catheter™ II+ References: 1. In-vitro test data available upon request. 2. Centers for Disease Control and Prevention “Guidelines for the Prevention of Intravascular
Catheter-Related Infections,” August 9, 2002, Volume 51.
3. National Kidney Foundation. NKF-K/DOQI Clinical Practice Guidelines for Vascular Access:
update 2000. AmJ Kidney Dis 2001; 37 (supl): S137-S81.
¥ Carbothane™ is a trademark of Noveon IP Holding Corp. Caution: U.S. Federal law limits this device to sale by or on order of a physician.
Bactroban® is a registered trademark of Smithkline Beecham Corporation.
Contents of unopened, undamaged package are sterile. Disposable. Refer to
ChloraPrep® is a registered trademark of Medi-Flex Hospital Products Corporation.
package insert for current warnings, precautions, and instructions for use.
ExSept® is a registered trademark of Double Diamond Partners LLC.
Contact Arrow International, Inc. for reference information on the above.
Hibiclens® is a registered trademark of Zeneca Limited Corporation.
CAN II-M 03/04 10M 2004 Arrow International, Inc. All rights reserved. Printed in the U.S.A.
Le citalopram est-il le médicament de première intention pour traiter la dépression de fin de vie? Le trouble dépressif majeur et les symptômes dépressifs chez les personnes âgées sont parmi les problèmes cliniques courants rencontrés par les gérontopsychiatres. Un essai récent mené dans le monde réel et portant sur l’efficacité des antidépresseurs pour traiter la dépression ma
Eur J Vasc Endovasc Surg xx, 1e7 (xxxx)doi:10.1016/j.ejvs.2006.04.033, available online onChronic Venous Disease Treated by Ultrasound GuidedAim. To report the outcome of a series of patients with chronic venous disease due to incompetence of saphenous trunksmanaged by ultrasound guided foam sclerotherapy (UFS). Patients and methods. A group of 808 patients comprise this series. CEAP clinical